NEW YORK (GenomeWeb News) – MorphoSys subsidiary AbD Serotec said today that it is collaborating with e2v Biosensors to develop a new protein-quantification system for point-of-care and near-patient testing.
 
The agreement builds on an initial project that the companies began in 2006 to use AbD’s HuCAL GOLD recombinant antibody technology with e2v’s Visucare single-antibody immunoassay technology.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.